By Staff Writer
THE Medicines Control Authority of Zimbabwe (MCAZ) has partnered a South African health products regulatory firm in a development set to strengthen systems between the two nations.
The MCAZ Friday signed a Memorandum of Understanding (MoU) with the South African Health Products Regulatory Authority (SAHPRA) which will allow the regulators to develop a cooperative partnership towards ensuring access to safe, quality, and effective health products in the respective countries.
The duo will cooperate in joint products reviews and inspections to enable efficient access to health products.
The partnership will also focus on detection and curbing of substandard and falsified health products moving between the two countries, which has of late been a major challenge that the two regulators have identified.
This landmark event marks a significant step towards strengthening the regulatory frameworks of both Zimbabwe and South Africa in the pharmaceutical sector. The MoU is designed to facilitate cooperation and collaboration between the two countries in the areas of medicines regulation, quality control, and pharmacovigilance”, shares MCAZ Director-General, Mr Richard Rukwata.
“The forging of partnerships such as this MoU with the Medicines Control Authority of Zimbabwe, a fellow African National Regulatory Authority, is key to further enhancing and building capacity on the continent”, indicates SAHPRA CEO, Dr Boitumelo Semete Makokotlela.
